Condition 1: Depression. Condition 2: Diabetes. Condition 3: sleep.
Conditions
Interventions
Intervention 1: Intervention group: Postmenopausal diabetic patients who adhere to the DASH diet. Intervention in this group of people receiving the DASH diet as a diet rich in antioxidants for three
Sponsors
Tehran University of Medical Sciences
Eligibility
Sex/Gender
Female
Inclusion criteria
Inclusion criteria: Tendency to participate in the study Patients with type 2 diabetes Postmenopause individuals (who don't have the period cycle for 12 months) Persons who dont adhere special diets
Exclusion criteria
Exclusion criteria: Patients with cancer, kidney, liver, heart and other specific diseases, patients with depression and other psychological diseases, New events which impact on patients mood Consumption of OCPs, hormonal supplements and hormone therapy Esterogen therapy during 3 last months Smoking Insulin therapy Consumption of supplements and vitamins during 2 last months Patients with depression and other psychological diseases, New events which impact on patients mood
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Luteinizing Hormone (LH). Timepoint: Before and after intervention (12wk). Method of measurement: Serum levels by ELISA.;Follicle Stimulating Hormone (FSH). Timepoint: Before and after intervention (12wk). Method of measurement: Serum levels by ELISA.;Sex Hormone Binding Globulin (SHBG). Timepoint: Before and after intervention (12wk). Method of measurement: Serum levels by ELISA.;Testestrone. Timepoint: Before and after intervention (12wk). Method of measurement: Serum levels by ELISA.;Advanced Glycation End products (AGEs). Timepoint: Before and after intervention (12wk). Method of measurement: Serum levels by ELISA.;Depression. Timepoint: Before and after intervention (12wk). Method of measurement: DASS-21 item questionnaire.;Sleep status. Timepoint: Before and after intervention (12wk). Method of measurement: Pittsburgh sleep questionnaire index (PSQI).;Anxiety. Timepoint: Before and after intervention (12 wk). Method of measurement: DASS-21 item questionnaire.;Stress. Timepoint: Before and after intervention (12 wk). Method of measurement: DASS-21 item questionnaire. | — |
Secondary
| Measure | Time frame |
|---|---|
| Weight. Timepoint: Before and after intervention (12 wk). Method of measurement: Scale.;Waist circumference. Timepoint: Before and after intervention (12 wk). Method of measurement: inflexible meter.;Blood pressure. Timepoint: Before and after intervention (12 wk). Method of measurement: Digital Sphygmomanometer.;Body Mass Index (BMI). Timepoint: Before and after intervention (12 wk). Method of measurement: Weight in kilogram divided to square of height in meter. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr Leila Azadbakht
Tehran University of Medical Sciences
Outcome results
None listed